ATLANTA — The non-profit Hamner Institutes for Health Sciences and China Medical City inked an agreement yesterday creating a new drug-development institute intended to create a biotechnology bridge between North Carolina and China.

The new institute, called the Hamner-China Medical City Institute for International Drug Development, will receive $5 million from Chinese-American CRO Newsummit Biopharma, and will attempt to leverage each partner's strengths in translational research, business development, and education to produce new biomedical technologies.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.